Anup Gupta
Anup Gupta has over 30 years of global experience in finance, strategy, M&A, and operations. He is a proven leader and mentor with an international and entrepreneurial outlook, and strong ability to lead large and diverse teams.
With deep expertise in healthcare products and services, Anup has held C-level roles at organizations such as DRG, Parexel, and Cambrex, and several earlier-stage companies in life sciences. In addition, he has served on the boards of Analytical Wizards, PlanetOne, and Scient (Asia). He has led global operations across more than 50 countries; completed acquisitions in the Americas, Europe, Asia, and Australia; and helped growth-stage startups achieve scale and critical mass.
Beyond his Board responsibilities at Amplity Health, he works with Nanobiosym, a new-age diagnostics company, to commercialize its technologies. Most recently, he was the Chief Financial Officer of CDMO Avara Pharmaceutical Services, CFO/advisor to data and analytics firm Analytical Wizards, and CFO of CDMO Escientia Life Sciences. He led the sale of the last two companies to strategic aquirers. Anup’s early career spanned consulting on IT, eBusiness, and Strategy with the likes of Accenture, Scient, and BCG.
Anup holds Bachelor of Science in Computer and Information Sciences from The National University of Singapore, and an MBA in Finance and Strategic Management from The Wharton School, where he graduated as a Palmer Scholar.
Beyond his Board responsibilities at Amplity Health, he works with Nanobiosym, a new-age diagnostics company, to commercialize its technologies. Most recently, he was the Chief Financial Officer of CDMO Avara Pharmaceutical Services, CFO/advisor to data and analytics firm Analytical Wizards, and CFO of CDMO Escientia Life Sciences. He led the sale of the last two companies to strategic aquirers. Anup’s early career spanned consulting on IT, eBusiness, and Strategy with the likes of Accenture, Scient, and BCG.
Anup holds Bachelor of Science in Computer and Information Sciences from The National University of Singapore, and an MBA in Finance and Strategic Management from The Wharton School, where he graduated as a Palmer Scholar.
Hensley Evans
Hensley is an accomplished strategic thinker and advisor with more than 30 years of experience in strategic and financial consulting in healthcare, pharmaceutical, and consumer health. Her passion is helping organizations identify the “sweet spot” at the intersection of improved patient experiences and outcomes and positive business impact.
Hensley is currently a Senior Partner at ZS Associates, a consulting and technology firm, where she founded the Patient and Consumer Health Practice globally. After building the practice in the US, she moved to Zurich in 2018 to expand operations in Europe. In 2022, she assumed leadership of the Global Business Transformation Practice, which includes organizational design, process excellence, change enablement, and human capital strategy. Her personal focus continues to be helping organizations transform to become more patient focused and deliver better health outcomes to patients. Prior to joining ZS, Hensley refined her marketing strategy and digital health skills over 15 years of leadership roles at marketing and advertising agencies, including Saatchi & Saatchi Health and Wellness, imc2 Health and Wellness, and Harte-Hanks, preceded by 10 years in strategic consulting at Price Waterhouse Coopers and Andersen Consulting.
Hensley currently serves on several boards, including HealthPrize, AMREF Health Africa, and the Wallkill Valley Land Trust, and received a BA in Economics from Duke University, and an MBA from the Wharton School of the University of Pennsylvania. She is an avid runner and rock climber and enjoys many other outdoor activities with her partner, Jason, and their daughter, Kaia.
Hensley currently serves on several boards, including HealthPrize, AMREF Health Africa, and the Wallkill Valley Land Trust, and received a BA in Economics from Duke University, and an MBA from the Wharton School of the University of Pennsylvania. She is an avid runner and rock climber and enjoys many other outdoor activities with her partner, Jason, and their daughter, Kaia.
Tony Hooper
Tony has been a Board member since January 2020, following an illustrious tenure at the world’s largest biotech organization, Amgen, where he served as Executive Vice President, Global Commercial Operations since 2011.
Prior to joining Amgen, Mr. Hooper held senior global leadership positions at Bristol-Myers Squibb (BMS), presiding over the Americas, Europe, Middle East, and Africa operations for over 11 years.
Prior to joining BMS, Mr. Hooper was Assistant Vice President of Global Marketing for Wyeth Laboratories.
He also currently serves on the boards of MannKind Corporation, BeiGene Ltd, and Lykan Biosciences.
Mr. Hooper earned Law and MBA degrees from the University of South Africa.
Prior to joining BMS, Mr. Hooper was Assistant Vice President of Global Marketing for Wyeth Laboratories.
He also currently serves on the boards of MannKind Corporation, BeiGene Ltd, and Lykan Biosciences.
Mr. Hooper earned Law and MBA degrees from the University of South Africa.